|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51178316
線上人數 :
839
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"sung hsin kuo"的相關文件
顯示項目 1-10 / 221 (共23頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-08-23T02:35:04Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu L.-S.; Wu Y.-W.; Chang J.T.-C.; Chang W.-T.; Chao T.-H.; Chen H.H.-W.; Chen Y.-J.; Cheng K.-H.; Hsu W.-L.; Hung C.-L.; SUNG-HSIN KUO; Liang J.-A.; Lin H.-J.; Liu P.-Y.; Liu W.-S.; Liu Y.-W.; Shueng P.-W.; Wang C.-Y.; Hou C.J.-Y.; Chiou J.-F.; TASTRO-TSOC Cardio-Oncology Task Force |
| 臺大學術典藏 |
2022-08-23T02:35:04Z |
Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)
|
Yang W.-C.; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; Cheng J.C.-H.; SUNG-HSIN KUO; Hsu F.-M. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; Yang S.-H.; Tien Y.-W.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-08-23T02:35:02Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang W.-T.; SUNG-HSIN KUO; Kuo Y.-C.; Lin C.-W. |
| 臺大學術典藏 |
2022-08-23T02:35:01Z |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
SUNG-HSIN KUO; Yeh K.-H.; Lin C.-W.; Liou J.-M.; Wu M.-S.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-23T02:35:00Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Bai L.-Y.; Hsu C.; Yang S.-H.; Lee J.-C.; Chen B.-B.; SUNG-HSIN KUO |
| 臺大學術典藏 |
2022-06-14T23:24:22Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Yang, Shih Hung; JEN-CHIEH LEE; BANG-BIN CHEN; SUNG-HSIN KUO; CHIUN HSU; Bai, Li Yuan |
| 臺大學術典藏 |
2022-05-17T07:54:35Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu, Long Sheng; YEN-WEN WU; Chang, Joseph Tung Chieh; Chang, Wei Ting; Chao, Ting Hsing; Chen, Helen Hai Wen; YU-JEN CHEN; Cheng, Kai Hung; Hsu, Wen Lin; Hung, Chung Lieh; SUNG-HSIN KUO; Liang, Ji An; HUNG-JU LIN; Liu, Ping Yen; Liu, Wen Shan; Liu, Yen Wen; Shueng, Pei Wei; Wang, Chao Yung; Hou, Charles Jia Yin; Chiou, Jeng Fong |
顯示項目 1-10 / 221 (共23頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
